Velarion Records
Free. Unsubscribe any time.

Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings, Inc. filed 27 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 9 reporting owners, covering 29 transactions and 529,317 shares. None carries the SEC's AFF10B5ONE flag; all 27 name a plan in a footnote. 9 results prints are on file in the same window.

What stands out

Trades in Xeris Biopharma Holdings, Inc. 29

Adoption dates in Xeris Biopharma Holdings, Inc. 6

Results prints in Xeris Biopharma Holdings, Inc. 9

Trades before a print in Xeris Biopharma Holdings, Inc. 6

Interval to Xeris Biopharma Holdings, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Xeris Biopharma Holdings, Inc. states

Filing text: “10b5-1 trading plan adopted by the reporting person on August 13, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.